Metraipolis › archive › dc_d04578efa84e

Case Report: Glomerular microangiopathy and reversible renal toxicity during prolonged bevacizumab therapy in ovarian cancer — Europe PMC PMID:41659714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41659714
DOI
10.3389/fonc.2026.1752830
License (as archived)
solo-consultazione
Archived
2026-11-06T12:57:00.343Z
SHA-256 of the archived text
57ab005adb638dcf7bf7628cc60fdc27ab7755462ca497c9084a670fb63fa69b
Stable URL of this page
https://metraipolis.com/documento/dc_d04578efa84e

How to cite

Case Report: Glomerular microangiopathy and reversible renal toxicity during prolonged bevacizumab therapy in ovarian cancer — Europe PMC PMID:41659714 — Europe PMC (en), https://europepmc.org/article/MED/41659714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d04578efa84e (Metraipolis archive dc_d04578efa84e, sha256 57ab005adb638dcf7bf7628cc60fdc27ab7755462ca497c9084a670fb63fa69b)
BibTeX
@misc{dcd04578efa84e,
  title = {Case Report: Glomerular microangiopathy and reversible renal toxicity during prolonged bevacizumab therapy in ovarian cancer — Europe PMC PMID:41659714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41659714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d04578efa84e; sha256 57ab005adb638dcf7bf7628cc60fdc27ab7755462ca497c9084a670fb63fa69b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41659714. Agents can read the archived copy with the MCP tool read_document.